| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
104,690,000 |
| Market
Cap: |
108.87(B) |
| Last
Volume: |
691,516 |
Avg
Vol: |
739,763 |
| 52
Week Range: |
$775.18 - $1201.76 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
| |
NASDAQ COMPOSITE |
|
S&P SMALLCAP 600 |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 963 |
| Guru Rank Value : 0.9 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
35,517 |
227,625 |
314,255 |
435,249 |
| Total Sell Value |
$40,560,781 |
$229,258,071 |
$307,884,459 |
$402,318,250 |
| Total People Sold |
9 |
12 |
16 |
19 |
| Total Sell Transactions |
15 |
33 |
71 |
131 |
| End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mccourt Marion |
EVP Commercial |
• – – |
2021-11-01 |
4 |
AS |
$640.00 |
$640,000 |
D/D |
(1,000) |
17,038 |
|
- |
|
| Mccourt Marion |
EVP Commercial |
• – – |
2021-11-01 |
4 |
OE |
$342.93 |
$342,930 |
D/D |
1,000 |
18,038 |
|
- |
|
| Ryan Arthur F |
Director |
– • – |
2021-11-01 |
4 |
AS |
$638.62 |
$64,252 |
D/D |
(100) |
23,091 |
|
- |
|
| Vagelos P Roy |
Director |
– • – |
2021-10-04 |
4 |
GD |
$0.00 |
$0 |
I/I |
347 |
141,630 |
|
- |
|
| Mccourt Marion |
EVP Commercial |
• – – |
2021-10-01 |
4 |
AS |
$576.75 |
$576,750 |
D/D |
(1,000) |
17,038 |
|
- |
|
| Mccourt Marion |
EVP Commercial |
• – – |
2021-10-01 |
4 |
OE |
$342.93 |
$342,930 |
D/D |
1,000 |
18,038 |
|
- |
|
| Ryan Arthur F |
Director |
– • – |
2021-10-01 |
4 |
AS |
$560.51 |
$56,949 |
D/D |
(100) |
23,191 |
|
- |
|
| Coles N Anthony |
Director |
– • – |
2021-09-15 |
4 |
AS |
$651.36 |
$7,873,484 |
D/D |
(11,948) |
902 |
|
- |
|
| Coles N Anthony |
Director |
– • – |
2021-09-15 |
4 |
OE |
$345.47 |
$4,372,807 |
D/D |
11,948 |
12,850 |
|
- |
|
| Zoghbi Huda Y |
Director |
– • – |
2021-09-14 |
4 |
AS |
$650.00 |
$648,700 |
D/D |
(998) |
891 |
|
- |
|
| Zoghbi Huda Y |
Director |
– • – |
2021-09-14 |
4 |
OE |
$391.92 |
$391,136 |
D/D |
998 |
1,889 |
|
- |
|
| Zoghbi Huda Y |
Director |
– • – |
2021-09-13 |
4 |
AS |
$651.10 |
$1,302 |
D/D |
(2) |
891 |
|
- |
|
| Zoghbi Huda Y |
Director |
– • – |
2021-09-13 |
4 |
OE |
$391.92 |
$784 |
D/D |
2 |
893 |
|
- |
|
| Brown Michael S |
Director |
– • – |
2021-09-13 |
4 |
AS |
$636.74 |
$6,289,792 |
D/D |
(9,704) |
891 |
|
- |
|
| Brown Michael S |
Director |
– • – |
2021-09-13 |
4 |
OE |
$380.95 |
$3,930,684 |
D/D |
9,704 |
10,595 |
|
- |
|
| Tessier-Lavigne Marc |
Director |
– • – |
2021-09-13 |
4 |
AS |
$636.64 |
$8,181,827 |
D/D |
(12,750) |
2,078 |
|
- |
|
| Tessier-Lavigne Marc |
Director |
– • – |
2021-09-13 |
4 |
OE |
$273.67 |
$3,489,293 |
D/D |
12,750 |
14,828 |
|
- |
|
| Goldstein Joseph L |
Director |
– • – |
2021-09-10 |
4 |
AS |
$650.00 |
$1,611,350 |
D/D |
(2,479) |
5,891 |
|
- |
|
| Goldstein Joseph L |
Director |
– • – |
2021-09-10 |
4 |
OE |
$380.95 |
$944,375 |
D/D |
2,479 |
8,370 |
|
- |
|
| Mccourt Marion |
EVP Commercial |
• – – |
2021-09-01 |
4 |
AS |
$674.72 |
$674,720 |
D/D |
(1,000) |
17,038 |
|
- |
|
| Mccourt Marion |
EVP Commercial |
• – – |
2021-09-01 |
4 |
OE |
$342.93 |
$342,930 |
D/D |
1,000 |
18,038 |
|
- |
|
| Ryan Arthur F |
Director |
– • – |
2021-09-01 |
4 |
AS |
$672.75 |
$67,628 |
D/D |
(100) |
23,291 |
|
- |
|
| Landry Robert E |
EVP Finance CFO |
• – – |
2021-08-31 |
4 |
D |
$675.03 |
$619,003 |
D/D |
(917) |
25,986 |
|
- |
|
| Landry Robert E |
EVP Finance CFO |
• – – |
2021-08-31 |
4 |
OE |
$555.67 |
$555,670 |
D/D |
1,000 |
26,903 |
|
- |
|
| Sing George L |
Director |
– • – |
2021-08-30 |
4 |
S |
$670.00 |
$369,100 |
I/I |
(550) |
1,750 |
|
- |
|
2459 Records found
|
|
Page 22 of 99 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
8.81 (0.85%) 
